首页> 外文OA文献 >Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities

【2h】

Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities

机译：放射性碘治疗分化型甲状腺癌：100至150 mCi碘-131活动的门诊治疗的放射学影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
SAPIENZA Marcelo Tatit; WILLEGAIGNON José; ONO Carla Rachel; WATANABE Tomoco; GUIMARÃES Maria Inês Calil Cury; GUTTERRES Ricardo Fraga; MARÉCHAL Maria Helena da Hora; BUCHPIGUEL Carlos Alberto;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi [J] . Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska-Suwińska, Thyroid Research . 2010,第1期

机译：分化型甲状腺癌（DTC）患者的放射性碘甲状腺残余消融：30、60和100 mCi长期治疗结果的前瞻性比较
2. Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer [J] . Abuqbeitah Mohammad, Demir Mustafa, Kabasakal Levent, Nuclear Medicine Communications . 2018,第11期

机译：间接评估在转移性分化甲状腺癌的放射性碘治疗中的剂量测定概念的最大经验活动（250mCI）
3. Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up [J] . Eleonora Molinaro, Carlotta Giani, Laura Agate, The journal of clinical endocrinology and metabolism . 2013,第7期

机译：重组人TSH或甲状腺激素治疗退出后接受低碘131I放射性碘甲状腺消融的分化型甲状腺癌患者在随访10年后仍显示相同的结果
4. Clinical Engineering and Clinical Dosimetry in Patients with Differentiated Thyroid Cancer Undergoing Thyroid Remnant Ablation with Radioiodine-131 [C] . M. Medvedec, D. Dodig 12th Mediterranean conference on medical and biological engineering and computing 2010 . 2010

机译：放射性碘131消融甲状腺分化型甲状腺癌患者的临床工程和临床剂量
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Lesion-Wise Comparison of Pre-Therapy and Post-Therapy Effective Half-Life of Iodine-131 in Pediatric and Young Adult Patients with Differentiated Thyroid Cancer Undergoing Radioiodine Therapy [O] . Praveen Kumar, Chandrasekhar Bal, Nishikant Avinash Damle, 2019

机译：碘131在小儿和年轻成年甲状腺癌接受放射碘治疗的患者治疗前和治疗后有效半衰期的病变智慧比较
7. Radioiodoterapia do carcinoma diferenciado da tireoide: impacto radiológico da liberação hospitalar de pacientes com atividades entre 100 e 150 mCi de iodo-131 Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities [O] . Marcelo Tatit Sapienza, José Willegaignon, Carla Rachel Ono, 2009

机译：分化型甲状腺癌的放射碘治疗：活动度在100至150 mCi的碘131患者的医院放疗的放射学影响

Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities

著录项

相似文献

相关主题

期刊订阅